| CTRI Number |
CTRI/2026/02/104976 [Registered on: 27/02/2026] Trial Registered Prospectively |
| Last Modified On: |
27/02/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Other |
|
Public Title of Study
|
A study to assess the symptom burden in cancer patients |
|
Scientific Title of Study
|
A descriptive study to assess the symptom burden in cancer patients undergoing treatment in GGSMCH, Faridkot, Punjab. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Arshleen Kaur |
| Designation |
Post Graduate Student |
| Affiliation |
University College of Nursing, Faridkot |
| Address |
University College of Nursing, Faridkot, Sadiq Road, Faridkot-151203
Punjab, INDIA
Faridkot
PUNJAB
151203
India |
| Phone |
9781084963 |
| Fax |
|
| Email |
arshleensaini@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Arshleen Kaur |
| Designation |
Post Graduate Student |
| Affiliation |
University College of Nursing, Faridkot |
| Address |
University College of Nursing, Faridkot, Sadiq Road, Faridkot-151203
Punjab, INDIA
Faridkot
PUNJAB
151203
India |
| Phone |
9781084963 |
| Fax |
|
| Email |
arshleensaini@gmail.com |
|
Details of Contact Person
Public Query
|
| Name |
Arshleen Kaur |
| Designation |
Post Graduate Student |
| Affiliation |
University College of Nursing, Faridkot |
| Address |
University College of Nursing, Faridkot, Sadiq Road, Faridkot-151203
Punjab, INDIA
Faridkot
PUNJAB
151203
India |
| Phone |
9781084963 |
| Fax |
|
| Email |
arshleensaini@gmail.com |
|
|
Source of Monetary or Material Support
|
| University College of Nursing, Faridkot, Sadiq Road, Faridkot-151203
Punjab, INDIA |
|
|
Primary Sponsor
|
| Name |
Arshleen Kaur |
| Address |
#147, Shalimar Garden, Near Baba Bidhi Chand Ji, Urban Estate, Phagwara, distt kapurthala, Punjab - 144401 |
| Type of Sponsor |
Other [self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Arshleen Kaur |
Guru Gobind Singh Medical College and Hospital |
Department of Radiation Oncology, Guru Gobind Singh Medical College and Hospital (GGSMCH) Sadiq Road, Faridkot, Punjab, India pincode:151203
Faridkot
PUNJAB |
9781084963
arshleensaini@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional research and ethical committee of university college of nursing, faridkot |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C00-D49||Neoplasms, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
90.00 Year(s) |
| Gender |
Both |
| Details |
• Adult patients above 18 years diagnosed with cancer.
• Patients undergoing treatment in GGSMCH, Faridkot
• Patients available at the time of data collection.
|
|
| ExclusionCriteria |
| Details |
• Patients who are not willing to participate.
• Patients who are not able to respond due to severe illness.
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| symptom burden among cancer patients undergoing treatment as measured by rotterdam symptom checklist at a single point in time |
symptom burden among cancer patients undergoing treatment as measured by rotterdam symptom checklist will be assesed at baseline |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| nil |
nil |
|
|
Target Sample Size
|
Total Sample Size="130"
Sample Size from India="130"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
11/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0"
Months="1"
Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study aims to assess the symptom burden among cancer patients undergoing treatment at Guru Gobind Singh Medical College & Hospital Punjab. Cancer remains a leading global health concern, as reported by the World Health Organization, with high incidence and mortality rates. Patients undergoing cancer treatment frequently experience multiple physical and psychological symptoms such as pain, fatigue, nausea, anxiety, and sleep disturbances, which collectively contribute to significant symptom burden and reduced quality of life. A quantitative descriptive cross-sectional design will be used, enrolling 130 adult cancer patients selected through convenient sampling. Data will be collected using a self-developed socio-demographic and clinical profile sheet and the standardized Rotterdam Symptom Checklist (RSCL). The study seeks to evaluate the level of symptom burden and examine its association with selected sociodemographic and clinical variables. Findings are expected to support systematic symptom assessment, improve supportive care strategies, and enhance overall patient well-being and quality of life. |